- This event has passed.
Leaders in Biobanking
October 14 - October 16
Innovations to Maintain Integrity and Maximize Investment in Biospecimens
Today, biospecimen collections are used by multiple research groups for various aims, from basic research through clinical trials. Useful biosamples must be collected to maintain their molecular integrity for specific (or unknown) downstream analysis. Thus, during research, biobanks are key infrastructures because at one time or another, these biospecimens have been stored in a biobank.
Cambridge Healthtech Institute’s Tenth International Leaders in Biobanking Congress addresses innovations in biospecimen science and infrastructure to support expanding applications. Maintaining the integrity of biospecimens allows biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best strategies for effective use of biospecimens within today’s cutting-edge biomedical research.